BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 37012651)

  • 21. Mitochondrial Role in Oncogenesis and Potential Chemotherapeutic Strategy of Mitochondrial Infusion in Breast Cancer.
    Patel PS; Castelow C; Patel DS; Bhattacharya SK; Kuscu C; Kuscu C; Makowski L; Eason JD; Bajwa A
    Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361782
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A gold-based inhibitor of oxidative phosphorylation is effective against triple negative breast cancer.
    Mertens RT; Kim JH; Ofori S; Olelewe C; Kamitsuka PJ; Kwakye GF; Awuah SG
    Biomed Pharmacother; 2024 Jan; 170():116010. PubMed ID: 38128183
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Triterpenoid Saponin AG8 from
    Mu LH; Wang LH; Yu TF; Wang YN; Yan H; Liu P; Yan C
    Oxid Med Cell Longev; 2020; 2020():7963212. PubMed ID: 33123316
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anticancer effects of α-mangostin in OVACAR-3 human ovarian carcinoma cells are mediated via involvement of reactive oxygen species, mitochondrial -mediated apoptosis, suppression of cell migration and invasion and m-TOR/PI3K/AKT signaling pathway.
    Yu Y; Fei Z; Qin L
    J BUON; 2020; 25(5):2293-2300. PubMed ID: 33277848
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gonadotropin-releasing hormone type II antagonist induces apoptosis in MCF-7 and triple-negative MDA-MB-231 human breast cancer cells in vitro and in vivo.
    Gründker C; Föst C; Fister S; Nolte N; Günthert AR; Emons G
    Breast Cancer Res; 2010; 12(4):R49. PubMed ID: 20630060
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MYC and MCL1 Cooperatively Promote Chemotherapy-Resistant Breast Cancer Stem Cells via Regulation of Mitochondrial Oxidative Phosphorylation.
    Lee KM; Giltnane JM; Balko JM; Schwarz LJ; Guerrero-Zotano AL; Hutchinson KE; Nixon MJ; Estrada MV; Sánchez V; Sanders ME; Lee T; Gómez H; Lluch A; Pérez-Fidalgo JA; Wolf MM; Andrejeva G; Rathmell JC; Fesik SW; Arteaga CL
    Cell Metab; 2017 Oct; 26(4):633-647.e7. PubMed ID: 28978427
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nuclear factor erythroid 2-related factor 2 protects bovine mammary epithelial cells against free fatty acid-induced mitochondrial dysfunction in vitro.
    Chen Y; Tang Y; Luo S; Jia H; Xu Q; Chang R; Dong Z; Gao S; Song Q; Dong H; Wang X; Li Z; Aboragah A; Loor JJ; Xu C; Sun X
    J Dairy Sci; 2021 Dec; 104(12):12830-12844. PubMed ID: 34538488
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alpha-mangostin as an inhibitor of GSK3β in triple-negative breast cancer.
    Dewi C; Fristiohady A; Amalia R; Bunggulawa EJ; Muchtaridi M
    J Biomol Struct Dyn; 2023 Jul; 41(10):4515-4521. PubMed ID: 35465844
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting EGFR of triple-negative breast cancer enhances the therapeutic efficacy of paclitaxel- and cetuximab-conjugated nanodiamond nanocomposite.
    Liao WS; Ho Y; Lin YW; Naveen Raj E; Liu KK; Chen C; Zhou XZ; Lu KP; Chao JI
    Acta Biomater; 2019 Mar; 86():395-405. PubMed ID: 30660004
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevention by Dietary Polyphenols (Resveratrol, Quercetin, Apigenin) Against 7-Ketocholesterol-Induced Oxiapoptophagy in Neuronal N2a Cells: Potential Interest for the Treatment of Neurodegenerative and Age-Related Diseases.
    Yammine A; Zarrouk A; Nury T; Vejux A; Latruffe N; Vervandier-Fasseur D; Samadi M; Mackrill JJ; Greige-Gerges H; Auezova L; Lizard G
    Cells; 2020 Oct; 9(11):. PubMed ID: 33114025
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting prooxidant MnSOD effect inhibits triple-negative breast cancer (TNBC) progression and M2 macrophage functions under the oncogenic stress.
    Al Haq AT; Tseng HY; Chen LM; Wang CC; Hsu HL
    Cell Death Dis; 2022 Jan; 13(1):49. PubMed ID: 35017469
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Peroxisome proliferator-activated receptor γ, coactivator 1α deletion induces angiotensin II-associated vascular dysfunction by increasing mitochondrial oxidative stress and vascular inflammation.
    Kröller-Schön S; Jansen T; Schüler A; Oelze M; Wenzel P; Hausding M; Kerahrodi JG; Beisele M; Lackner KJ; Daiber A; Münzel T; Schulz E
    Arterioscler Thromb Vasc Biol; 2013 Aug; 33(8):1928-35. PubMed ID: 23788763
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phenethyl isothiocyanate induces DNA damage-associated G2/M arrest and subsequent apoptosis in oral cancer cells with varying p53 mutations.
    Yeh YT; Yeh H; Su SH; Lin JS; Lee KJ; Shyu HW; Chen ZF; Huang SY; Su SJ
    Free Radic Biol Med; 2014 Sep; 74():1-13. PubMed ID: 24952138
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mitophagy regulates mitochondrial network signaling, oxidative stress, and apoptosis during myoblast differentiation.
    Baechler BL; Bloemberg D; Quadrilatero J
    Autophagy; 2019 Sep; 15(9):1606-1619. PubMed ID: 30859901
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dietary whey protein stimulates mitochondrial activity and decreases oxidative stress in mouse female brain.
    Shertzer HG; Krishan M; Genter MB
    Neurosci Lett; 2013 Aug; 548():159-64. PubMed ID: 23748211
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ginsenoside Rh1 inhibits tumor growth in MDA-MB-231 breast cancer cells via mitochondrial ROS and ER stress-mediated signaling pathway.
    Jin Y; Huynh DTN; Heo KS
    Arch Pharm Res; 2022 Mar; 45(3):174-184. PubMed ID: 35325393
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapeutic cooperation between auranofin, a thioredoxin reductase inhibitor and anti-PD-L1 antibody for treatment of triple-negative breast cancer.
    Raninga PV; Lee AC; Sinha D; Shih YY; Mittal D; Makhale A; Bain AL; Nanayakarra D; Tonissen KF; Kalimutho M; Khanna KK
    Int J Cancer; 2020 Jan; 146(1):123-136. PubMed ID: 31090219
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diterpenoid natural compound C4 (Crassin) exerts cytostatic effects on triple-negative breast cancer cells via a pathway involving reactive oxygen species.
    Richards CE; Vellanki SH; Smith YE; Hopkins AM
    Cell Oncol (Dordr); 2018 Feb; 41(1):35-46. PubMed ID: 29134467
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cepharanthine sensitizes human triple negative breast cancer cells to chemotherapeutic agent epirubicin via inducing cofilin oxidation-mediated mitochondrial fission and apoptosis.
    Shen LW; Jiang XX; Li ZQ; Li J; Wang M; Jia GF; Ding X; Lei L; Gong QH; Gao N
    Acta Pharmacol Sin; 2022 Jan; 43(1):177-193. PubMed ID: 34294886
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chetomin induces apoptosis in human triple-negative breast cancer cells by promoting calcium overload and mitochondrial dysfunction.
    Dewangan J; Srivastava S; Mishra S; Pandey PK; Divakar A; Rath SK
    Biochem Biophys Res Commun; 2018 Jan; 495(2):1915-1921. PubMed ID: 29208466
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.